HLB Pep Co., Ltd. (KOSDAQ: A196300)
Health Care · Biotechnology · KR
₩4,650.00
-1.80% today · -40.1% 1Y
HLB Pep Co., Ltd. (KOSDAQ: A196300) operates in the Biotechnology industry within the Health Care sector. The company is valued at $31.46M.
Over the last twelve months the share price has lost 40.1%, trading between 3.51K and 9.53K.
Tweenvest scores HLB Pep Co., Ltd. across four factors: quality 36/100, value 56/100. Its strongest factor is value.
A196300 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.46M
- Revenue (TTM)
- $3.58M
- P/E
- —
- EPS
- -993.92
- Dividend yield
- —
- Beta (5Y)
- 0.21
- 52-week high
- ₩9,530.00
- 52-week low
- ₩3,510.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.38M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.93 | +0.53% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $445.08 | +0.28% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $147.46 | +0.49% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $553.68 | +1.11% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $836.15 | +0.92% |
| argenx SEENXTBR: ARGX | $63.06B | €877.40 | +1.53% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $156.39 | +12.60% |
Figures last refreshed Aug 18, 2026.